RIDE24 gains Race Across America qualifying status
RIDE24 has become the first UK track event to gain Race Across America (RAAM) qualifier status for solo riders looking to prove they are good enough to take on the world-famous ultra-endurance cycling race.
Organised annually by children’s charity Action Medical Research and operated under British Cycling technical regulations, RIDE24 is the UK’s only 24-hour cycling endurance track event. This year’s ride takes place at Goodwood Motor Racing Circuit in Sussex on 18 and 19 June and is still open for final registrations.
RIDE24 sees participants compete to travel the greatest distance in 24 hours. The event is open to both teams and solo riders, with winners in each of the following categories: four-man team, six-man team, mixed-sex team, all-female team, veterans and solo rider. It is backed by IG Markets, the leading provider of Contracts for Difference, and will be attended by cycling legend Chris Boardman.
RAAM is a non-stop, 3,000 mile, coast-to-coast ride, which usually takes at least eight days for the fittest and fastest riders to complete. Action Medical Research supporter Chris Armishaw, from Billericay, is the first rider signed up to attempt the RAAM qualifying standard in this year’s RIDE24 event. The 46-year-old plans to take on RAAM in 2012 to try and raise £50,000 for the charity, which helps fund vital medical research into conditions affecting babies and children.
RAAM’s Race Director, Fred Boethling said: “We are delighted to include RIDE24 as a UK qualifying event for Race Across America. Riding for 24 hours non-stop should give solo participants a very small idea of what they will need to put themselves through should they brave the challenge of RAAM.”
The winning RIDE24 four-man team will also secure themselves a free place in the French 24 Heures Velo event at the legendary Circuit Bugatti in Le Mans, and Swiss watchmaker Roamer will present a watch to the rider who completes the fastest lap.
- ENDS -
NOTES TO EDITORS:
For more information please contact:
The circuit at Goodwood will give RIDE24 riders a 2.4-mile smooth, slightly undulating, circular track. When not in the saddle, competitors can recover in a rider village, which includes camping facilities, 24-hour hot and cold food and snacks, massage area, first aid and mechanical support.
Cyclists participating in RIDE24 raise money to help fund medical research into conditions affecting babies and children. Last year’s event raised more than £85,000 for the charity.
Action Medical Research has 30 years experience in organising successful bike rides. Routes are monitored and clearly signposted. Snack and lunch stops are provided and medical and mechanical staff are on hand at all times.
Action Medical Research is the leading UK-wide medical research charity dedicated to helping babies and children. We know that medical research can save and change children’s lives. For nearly 60 years we have been instrumental in significant medical breakthroughs, including the development of the UK polio vaccine and ultrasound scanning in pregnancy.
Today, we continue to find and fund the very best medical research to help stop the suffering of babies and children caused by disease and disability. We want to make a difference in:
• tackling premature birth and treating sick and vulnerable babies
• helping children affected by disability, disabling conditions and infections
• targeting rare diseases that together severely affect many forgotten children.
For more information about Race Across America visit www.raceacrossamerica.org
For more information about the 24 Heures Velo event visit 24heuresvelo.fr
About IG Markets:
IG Markets is an international market-maker in financial derivatives, offering clients the ability to trade on over 8,000 shares, indices, currencies, commodities and treasuries from markets across the globe. IG Markets is part of IG Group (IGG.L), which employs in excess of 900 people and has offices in 14 countries worldwide. For further information please visit www.igmarkets.co.uk or www.iggroup.com, or call +44 (0) 20 7896 0011.